The opinions and statements made in videos and interviews are those of the contributors. The grantors, editors, editorial board or Secretariat do not necessarily share the views expressed. No liability on the part of the grantors, editors, editorial board or Secretariat is accepted for the consequences of any misleading or inaccurate information.
Videos
Expert views and opinionInternational experts discuss hot topics in the prevention of migraine in patients worldwide.
PRODROME results published in The Lancet
한국의 두통 연구에 관해 몇 가지 말씀해 주시겠습니까?
한국에서의 편두통 치료 개선을 위해 어떤 변화가 도움이 되겠습니까?
편두통 치료법 사용에 관련하여 의사들에게 어떤 조언을 하시겠습니까?
Can you tell us about some of the headache research in Korea?
What changes would help to improve migraine care in Korea?
What advice would you give doctors about using migraine therapies?
한국에서 편두통은 얼마나 흔합니까?
한국에서 편두통 진단은 어떻게 합니까?
한국에는 어떤 편두통 치료법이 있습니까?
항CGRP 치료법은 한국에서의 연구와 임상 진료에서 얼마나 효과가 있었습니까?
How effective have anti-CGRP therapies been in Korean studies and in clinical practice?
Which migraine therapies are available in Korea?
How is migraine diagnosed in Korea?
How common is migraine in Korea
What advice would you give doctors about using migraine therapies?
What changes are needed to improve migraine care in India?
What is your experience of using migraine therapies for episodic and chronic migraine and medication overuse headache?
How are migraine attacks prevented in India?
How is acute migraine treated in India?
What are the specific reasons why migraine is under-diagnosed in India?
Is migraine under-diagnosed in India and what are the barriers to diagnosis?
What are the main triggers for migraine in India?
How common is migraine in India?
What advice do you give clinicians talking to insurers about reimbursement?
Can clinicians combine anti-CGRP therapies with other treatments?
ما هي النصيحة التي تقدمها للأطباء الذين يتحدثون لشركات التأمين حول تسديد تكاليف العلاج؟
هل يمكن للأطباء الجمع بين العلاجات المضادة لـ CGRP والعلاجات الأخرى المستخدمة؟
How can clinicians identify suitable patients for anti-CGRP therapies?
How well do patients respond to anti-CGRP therapies?
كيف يمكن للأطباء تحديد المرضى المناسبين للعلاجات المضادة لـ CGRP؟
ما مدى استجابة المرضى للعلاجات المضادة لـ CGRP؟
In the Middle East, how common is migraine and what medicines are used?
What are the main treatment problems and how can these be addressed?
ما مدى انتشار الصداع النصفي (الشقيقة) في الشرق الأوسط وما هي الأدوية المستخدمة؟
ما هي المشاكل الرئيسية في العلاج وكيف يمكن التعامل معها؟
What advice would you give clinicians about how patients can obtain reimbursement for anti-CGRP therapies?
Que conselhos daria aos médicos para ajudar os pacientes a obter o reembolso de terapias anti-CGRP?
O que os médicos devem saber sobre a combinação de terapias anti-CGRP com outros tratamentos para a migrânea?
What should clinicians know about combining anti-CGRP therapies with other migraine treatments?
Quais pacientes podem se beneficiar das terapias anti-CGRP e como é o acompanhamento de terapias anti-CGRP?
Which patients in Brazil are suitable for anti-CGRP therapies and how do you follow up people on anti-CGRP therapies?
Quão boas são as evidências apoiando as terapias anti-CGRP?
Quais são os principais problemas enfrentados pelos médicos que tratam a migrânea no Brasil?
Quão comum é a migrânea no Brasil e como ela é tratada
How good is the evidence supporting anti-CGRP therapies?
What are the main problems for doctors treating migraine in Brazil?
How common is migraine in Brazil and how is it treated?
Combining CGRP mAbs and gepants: what do we know?
2020 brought new hope for patients with migraine – how will 2021 build on this success?
Anti-CGRP therapies – what did we learn in 2020 and what can we expect in 2021?
Migraine: a new treatment landscape
CGRP in cluster headache
CGRP therapies in acute migraine
What next for anti-CGRP therapy?
Become a member of CGRP Forum
Why is CGRP an important therapeutic target?
